Search Results - "Caterinicchia, Valerie"

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer by Stringer-Reasor, Erica M, May, Jori E, Olariu, Eva, Caterinicchia, Valerie, Li, Yufeng, Chen, Dongquan, Della Manna, Deborah L, Rocque, Gabrielle B, Vaklavas, Christos, Falkson, Carla I, Nabell, Lisle M, Acosta, Edward P, Forero-Torres, Andres, Yang, Eddy S

“…Poly (ADP-ribose)-polymerase inhibitors (PARPi) have been approved for cancer patients with germline BRCA1/2 (gBRCA1/2) mutations, and efforts to expand the…”
Get full text

An open label, pilot study of veliparib (ABT-888) and lapatinib in patients with metastatic, triple negative (ER, PR, and HER-2 negative) breast cancer by Stringer-Reasor, Erica Michelle, Yang, Eddy Shih-Hsin, May, Jori E., Caterinicchia, Valerie, Li, Yufeng, Forero-Torres, Andres

“…Abstract only…”
Get full text

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer by Forero-Torres, Andres, Saleh, Mansoor N, Galleshaw, Janice A, Jones, Cheryl F, Shah, Jatin J, Percent, Ivor J, Nabell, Lisle M, Carpenter, John T, Falkson, Carla I, Krontiras, Helen, Urist, Marshall M, Bland, Kirby I, De Los Santos, Jennifer F, Meredith, Ruby F, Caterinicchia, Valerie, Bernreuter, Wanda K, O'Malley, Janis P, Li, Yufeng, LoBuglio, Albert F

“…Abstract Introduction Tumor content or expression of vascular endothelial growth factor (VEGF) is associated with impaired efficacy of antiestrogen adjuvant…”
Get full text